Even before its acquisition by Abbott, St. Jude Medical had begun developing a dual-chamber leadless pacemaker, which would be a first if it succeeds.
Abbott and Medtronic are the only companies that have developed single-chamber leadless pacemakers; St. Jude recalled its version, Nanostim, in October 2017 after receiving 7 reports of lost telemetry and pacing output.
Get the rest of the story at our sister site, Medical Design & Outsourcing.
The post Abbott is developing a dual-chamber leadless pacer appeared first on MassDevice.
from MassDevice https://ift.tt/2JoAcMT
Cap comentari:
Publica un comentari a l'entrada